1.Epidemiological study of chronic kidney disease with children of gender difference
Mindong GAO ; Xia GAO ; Hong XU ; Yipa SAI ; Xiaofeng CAO ; Wenping YOU ; Xiaoyan LEI
International Journal of Pediatrics 2015;42(2):207-209
Objective To investigate the positive ratio of urine and gender difference of chronic kidney disease(CKD) with children in Lanzhou,a heavy pollution and underdeveloped city in northwest of China.Methods Through the Multistix 10 SG,the morning urine of the children were detected,which aged from 12 to 13 years old.Results The positive ratio of urine was 14.9% in subjects,18.2% in girls and 12.8 % in boys respectively.Furthermore,the positive ratio in girls showed statistically significant higher than boy's.(x2 =21.77,P < 0.01).Espcially,the ratios of hematuria and pyuria significantly increased in girls (x2 =17.52,P < 0.01;x2=7.95,P < 0.01).Conclusion The gender difference of the positive rate of urine was existed in our large samples.And there is a higher prositive rate of hematuria and pyuria in the girls.This investigation will enrich the epidemiological data of CKD in children(12 ~ 13 years old)in Lanzhou city.
2.Effect of rituximab combined with immunosuppressive pulse therapy for thy-roid-associated ophthalmopathy and its influence on clinical activity score and prognosis
Wei LI ; Yong YOU ; Fenfen XIANG ; Yongfeng YAN ; Kai CHEN ; Wenping CHEN
Recent Advances in Ophthalmology 2024;44(9):714-718
Objective To investigate the efficacy of rituximab combined with immunosuppressive pulse therapy for thyroid-associated ophthalmopathy(TAO)and analyze its influence on clinical activity score(CAS)and prognosis.Meth-ods A total of 136 patients(272 eyes)with TAO who were admitted to Huanggang Central Hospital from March 2020 to October 2022 were selected and divided into an observation group(68 patients)and a control group(68 patients)using a random number table method.Patients in the control group were given immunosuppressive pulse therapy,while patients in the observation group were given rituximab plus immunosuppressive pulse therapy.Both groups were treated for 4 courses(7 days per course).The clinical efficacy,eye signs,CAS score,thyroid conditions[thyrotropin receptor antibody(TRAb),thyroid peroxidase antibody(TPOAb),thyroid volume],T lymphocyte subsets,and adverse reactions were compared between the two groups.After a follow-up period of six months,the prognosis of patients in the two groups was compared.Results After 4 courses of treatment,the total effective rate of patients in the observation group was 94.12%(64/68),which was higher than that in the control group(82.35%,56/68)(P<0.05).After 2 and 4 courses of treat-ment,the degree of exophthalmos,intraocular pressure,average palpebral fissure width,retrobulbar soft tissue volume,distance from the bulbus oculi,CAS score,TPOAb,TRAb,and thyroid volume of patients in the observation group were smaller than those in the control group,and all decreased compared to before treatment(all P<0.05);the thickness of the tear film lipid layer was greater than that in the control group,and both increased compared to before treatment(all P<0.05).There were no significant differences in the said indicators between the two groups before treatment(all P>0.05).The CD3+,CD4+,and CD8+T lymphocyte levels of patients showed no significant difference between the two groups before treatment(all P>0.05).After 2 and 4 courses of treatment,the levels of CD3+and CD4+T lymphocyte in both groups were higher than those before treatment.Except that the CD4+T lymphocyte level in the observation group was lower than that in the control group after 2 courses of treatment,the levels of CD3+and CD4+T lymphocyte in the obser-vation group were higher than those in the control group at other time points(all P<0.05).After 2 and 4 courses of treat-ment,the level of CD8+T lymphocyte in both groups decreased compared to before treatment,and it was lower in the ob-servation group than the control group(all P<0.05).There was no significant difference in the incidence of adverse reac-tions such as low fever,nausea,and hypokalemia between the two groups(all P<0.05).After the 6-month follow-up,the improvement rate of patients in the observation group was 95.59%(65/68),which was higher than that in the control group(79.41%,54/68)(P<0.05).Conclusion Rituximab combined with immunosuppressive pulse therapy is effec-tive for TAO.It can alleviate eye signs and thyroid conditions,reduce clinical activity,and promote prognosis.
3.Multicystic Encephalomalacia:Report of One Case.
Huan XU ; You LIU ; Xue WANG ; Wenping FAN ; Zhiye CHEN
Acta Academiae Medicinae Sinicae 2019;41(6):866-870
The magnetic resonance imaging findings of multicystic encephalomalacia are featured by bilateral frontal large cystic lesion with corpus callosum involvement,evident heterogeneous enhancement of the lesion margin,ring hyperintensity on diffusion weighted imaging,and high choline peak and low N-acetylaspartate peak of the enhanced lesion margin on magnetic resonance spectroscopy.This article reports a case of multicystic encephalomalacia.
Corpus Callosum
;
Encephalomalacia
;
Humans
;
Magnetic Resonance Imaging
;
Magnetic Resonance Spectroscopy